Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Solara Active Pharma Sciences has uploaded the audio recording of its Q1 FY27 earnings call held on July 23, 2026. The call discussed the unaudited financial results for the quarter ended June 30, 2026, and the recording is available on the company's website.
Jul 23 2026 19:16:53
Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Solara Active Pharma Sciences received a monitoring agency report confirming no deviation in the utilization of Rs.449.95 crore raised through its Rights Issue. The funds were used as per the stated objects for the quarter ended June 30, 2026.
Jul 23 2026 17:27:22
Solara Active Pharma Sciences Ltd - 541540 - Statement Of Deviation And Variation For Funds Raised Under Rights Issue For The Quarter Ended June 30, 2026.
Solara Active Pharma Sciences confirmed no deviation or variation in the utilization of proceeds from its Rights Issue for the quarter ended June 30, 2026. This indicates proper financial management and adherence to the stated objectives of the fundraise.
Jul 23 2026 16:40:43
Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Solara Active Pharma Sciences announced Q1 FY27 results with revenue of Rs.384.3 crore (up 20% YoY) and PAT of Rs.16.3 crore (up 55% YoY). The company achieved its highest EBITDA and PAT in the last eighteen quarters, supported by strong base business performance and significant debt reduction.
Jul 23 2026 13:30:11
Solara Active Pharma Sciences Ltd - 541540 - Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended June 30, 2026.
Solara Active Pharma Sciences reported Q1 FY27 cons. revenue of ₹381.60 cr, up 19.56% YoY, and net profit of ₹16.31 cr, up 55.04% YoY. The board also re-affirmed its going concern status and noted progress on a CRAMS & Polymers demerger plan.
Jul 23 2026 13:17:30
Solara Active Pharma Sciences Ltd - 541540 - Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 ('Listing Regulations')
Solara Active Pharma Sciences' Board of Directors will hold a meeting on July 23, 2026, to review and approve the unaudited financial results for the quarter ended June 30, 2026.
Jul 16 2026 19:59:31
Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Solara Active Pharma Sciences has issued a final reminder-cum-forfeiture notice for the payment of first and second call money on its partly paid-up equity shares. The payment window is from July 13 to July 27, 2026. Failure to pay may result in forfeiture of the shares.
Jul 09 2026 17:47:38
Read More